INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
110 hedge funds and large institutions have $136M invested in Insys Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 103 → 110 (+7)
Holders
110
Holding in Top 10
–
Calls
$5.49M
Puts
$4.68M
Top Buyers
| 1 | +$2.22M | |
| 2 | +$1.52M | |
| 3 | +$1.21M | |
| 4 |
Millennium Management
New York
|
+$1.2M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.01M |
Top Sellers
| 1 | -$4.87M | |
| 2 | -$824K | |
| 3 | -$433K | |
| 4 |
Barclays
London,
United Kingdom
|
-$407K |
| 5 |
VF
Virtu Financial
New York
|
-$253K |